Company intelligence / Profile preview

Form Collective

Dallas, Texas, USA

Ownership: Private
Development stage: Other

Overview

Form Bio offers award-winning software and AI solutions that accelerate the development of cell and gene therapies by enabling rapid in silico characterization, prediction, simulation, and optimization. Their tools help improve safety profiles, manufacturing yields, efficacy predictions, and reduce time/cost to clinic for biopharma partners developing advanced therapeutics. The company recently established a Scientific Advisory Board with leading experts in vector engineering to further advance their capabilities in viral vector design.

Modalities: Gene therapyCell therapyViral vector-based therapies (notably AAV)In silico drug development tools and platforms
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Form Collective.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Form Collective.

Explore the full profile